LiveWorld
Independent
Address
2105 S. Bascom Ave., Suite 159
Campbell, California 95008
Web Address
Year Founded
1996
North American Revenue 2022
Full-time Employees 2022
Number of clients 2022
Offices
North America
2
Locations
Campbell, CA
New York, NY
Executives & Senior Management
Peter Friedman
Chairman and Chief Executive Officer
Dawn Lacallade
VP, Healthcare, Chief Social Strategist
Jena Dengrove
VP, Creative Director
Senior Management
Peter Friedman
Chairman and Chief Executive Officer
David Houston
Chief Financial Officer
Martin Bishop
VP, Client Services
Dawn Lacallade
VP, Healthcare, Chief Social Strategist
Umar Siddiqui
MD, Chief Medical Officer
Jena Dengrove
VP, Creative Director
Danny Flamberg
VP, Strategy
Rishi Kadiwar
VP, Strategy
Matthew Hammer
VP, Marketing
Jason Liebowitz
VP, Sales
Tashona White
Human Resources Director
Agency 100 T-Shirt
Capabilities/Services Offered
Professional
Consumer
OTC
Direct Marketing
Media Planning
Med-ed
Payer
Med-Tech
Public Health
Data/Analytics
Digital
Medical affairs
New Services
Twitter competitive sweeping: Identify trending competitor content
Twitter reputation risk management: Pharma brand reputation risk management on Twitter to detect false accounts
Instagram tag search: Ability to search for specific hashtags in Instagram for moderation
List management: Development of customized lists of target audiences
New Roles
Roles Added
1
Roles
Tashona White - Human Resources Director
Client Roster
AbbVie Corp US, Corp Canada - QUILIPTA/Atogepant, Botox Cosmetics, Botox Chronic Migraine, Botox Spasticity, ORIAHNN, Orlissa, Humira, Juvederm, Rinvoq, Synthroid, Skyrizi, Ubrelvy, Venclexta, Navitoclax, Coolsculpting
Amryt (Chiasma) - MYCAPSSA, Juxtapid, Myalept
AstraZeneca Global Corp. -
Calquence, IMFINZI, LYNPARZA, TAGRISSO, BREZTRI, BRILINTA, BYDUREON, FARXIGA, FASENRA, FLUMIST, ENHERTU, EVUSHELD, LOKELMA, SAPHNELO, TEZSPIRE
Axogen - Nerve Repair
Bristol Myers-Squibb, corporate brand BMS, Global Corporate - REVLIMID, Ozanimod, Zeposia
Boehringer Ingelheim
CHPA
Chiesi - Lamzede (Alpha Mannosidosis), PRX-102 (Fabry Disease), El Fabrio, Revcovi (ADA-SCID), Raxone (OLOHN), Procysbi (Neohropathic Cystinosis), Ferriprox (Sickle Cell)
Cytokinetics
Daiichi Sankyo Corporate
Gilead
Gilead Sciences
Kite Pharma
Cayston
Idorsia - QUVIVIQ
LabCorp
Mass General
Mount Sinai
Novocure - Optune
Nutricia Real Food Blends - Neocate, ProStat, Souvenaid
Pfizer Corporate - Prevnar, Tafimidis, Vyndamax, Paxlovid, Covid vaccine, iBrance
Rite Aid
SOBI - Synagis
TherapeuticsMD - Annovera, Imvexxy
Zoetis Corporate - Apoquel, Cytopoint, Simparica, Solensia
Growth
2022 Growth from Existing Clients
57%
2022 Growth from New Clients
43%
Trends and Challenges
Getting an audience, virtually or otherwise, with HCPs
Client losses in the wake of pharma M&A
Replenishing new-business pipeline
Healthcare Marketing Trends
More personalization of communications
Need to create more/better content/experiences
Increased concern over drug pricing
Scrutiny around social media
Impact of empowered patients/consumers
Decreased impact of sales forces
Programs that go “beyond the pill”
Emphasis on specialty drugs/high-science categories
More digital experimentation
Working from home
Creative Samples
